Dinesh Bahl, MD
Retina Specialist · El Paso, TXNPI 1295837466
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.1%), ownership interests and gifts — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by US Retina LLC at 45.7% of the total. Reporting peaked in 2022 at $3,542 and has fallen 67.2% since, to $1,160 in 2025.
Across 102 payments — averaging $128.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$6K
- Alcon$2K
- Regeneron Healthcare Solutions, Inc.$833
- Genentech USA, Inc.$745
- AbbVie$709
- Regeneron$613
- plus $2K from 17 others
What the payments were for
- Food & beverage$7,09754%
- Gifts$190%
- Ownership interest$5,99246%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 6 | $5,992 |
| Alcon | 16 | $1,853 |
| Regeneron Healthcare Solutions, Inc. | 11 | $833 |
| Genentech USA, Inc. | 8 | $745 |
| AbbVie(2 entities) | 26 | $709 |
| Regeneron | 5 | $613 |
| Carl Zeiss Meditec USA, Inc. | 5 | $434 |
| Astellas Pharma US Inc | 3 | $353 |
| Biogen | 2 | $165 |
| Sandoz | 2 | $143 |
| US Oncology Corporate, Inc. | 1 | $139 |
| Eyepoint US, Inc. | 1 | $131 |
| Apellis Pharmaceuticals, Inc. | 1 | $123 |
| Harrow Eye, LLC | 2 | $116 |
| Bausch & Lomb Americas Inc. | 1 | $111 |
| Alimera Sciences, Inc. | 2 | $110 |
| Novartis | 1 | $100 |
| Coherus Oncology, Inc. | 1 | $100 |
| Spark Therapeutics, Inc. | 1 | $99 |
| Genentech, Inc. | 2 | $89 |
| Optos, Inc. | 1 | $78 |
| Inspire Medical Systems, Inc. | 3 | $55 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$1,195
- EYLEA$884
- VABYSMO$381
- EYLEA HD$348
- Lucentis$252
- OZURDEX$251
- Unity$245
- Izervay$236
- VERACITY SURGICAL$160
- DEXYCU$131
- Syfovre$123
- SUSVIMO$122
- VISUDYNE$111
- Retina Workplace$108
- BEOVU$100
How this compares
$13,109 in reported general payments places this provider in the 85th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 122 | $4,948 |
| Ketorolac Tromethamine | 61 | $2,625 |
| MoxifloxacinMoxifloxacin Hcl | 85 | $2,578 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 14 | $1,118 |
| Cyclopentolate Hcl | 44 | $780 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in El Paso
- Jeremy CuthbertsonEl Paso$12K
- David MetrikinEl Paso$11K
- Daniel KasugaEl Paso$9K
- Gregory TrubowitschEl Paso$8K
- Richard HwangEl Paso$3K
- Erica Alvarez GonzalezEl Paso$2K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.